Navigation Links
ResMed Announces Conference Call And Webcast To Discuss Third Quarter 2013 Results
Date:4/3/2013

SAN DIEGO, April 3, 2013 /PRNewswire/ -- RESMED INC. (NYSE: RMD) announced today that on Thursday, April 25, 2013, it will release its results for the third quarter and nine months of fiscal year 2013, ended March 31, 2013. A press release with ResMed's results will be issued after 1:00 p.m. US Pacific Time and the company will host a conference call and webcast to review its results, market trends, and future outlook.

(Logo: http://photos.prnewswire.com/prnh/20100203/RESMEDLOGO)

The conference call is scheduled to begin at 1:30 p.m. US Pacific Time and will be webcast on ResMed's website at http://investor.resmed.com.  Please go to this section of the website 5-10 minutes before the call and click on the icon for the "Q3 2013 results webcast." The online archive of the broadcast will be available approximately 30 minutes after the live call and will continue to be available for two weeks.

International conference call times will be:9:30 p.m.

London6:30 a.m.

Sydney, Australia (April 26, 2013)TO PARTICIPATE in the conference call, please call one of the numbers below at least 10 minutes before the call begins and identify yourself to the operator:US:

847-585-4405 Outside US:

+1 847-585-4405Conference Name:

Q3 2013 ResMed Inc. Results Conference Call  Participant Passcode:

34598681The replay of the conference call will be available approximately 30 minutes after the call and will be accessible for two weeks at:US:

630- 652-3042Outside US:

+1 630-652-3042Passcode:

34598681ResMed is a global leader in the development, manufacturing, and marketing of medical products for the diagnosis, treatment and management of respiratory disorders, with a focus on sleep-disordered breathing. The company is dedicated to developing innovative products to improve the lives of those who suffer from these conditions and to increasing awareness among patients and healthcare professionals of the potentially serious health consequences of untreated sleep-disordered breathing. Further information can be obtained by contacting Constance Bienfait at ResMed Inc. at +1 (858) 836-5971, or by visiting the company's website at www.resmed.com.


'/>"/>
SOURCE ResMed Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. ResMed Takes Action to Enforce Patents
2. Buoyed by Forecasts, Where 2013 Leads - Research Report on ResMed Inc., Zimmer Holdings, Inc., Waters Corporation, Covidien PLC, and Medtronic, Inc.
3. ResMed Inc. Announces Record Financial Results For The Quarter Ended And Six Months Ended December 31, 2012
4. ResMed Inc. Announces Exchange Rate For Upcoming Dividend Payment
5. ResMed Inc. Announces Record Financial Results for the Quarter Ended September 30, 2012
6. ResMed Inc. Announces Record Financial Results For The Quarter And Twelve Months Ended June 30, 2012
7. ResMed Announces Conference Call And Webcast To Discuss Fourth Quarter And Fiscal Year-End 2012 Results
8. ResMed Launches Narval™ CC Mandibular Repositioning Device in the US
9. ResMed Inc. Announces Plan To Initiate Dividend And Update On Chief Executive Officer Succession
10. Akorn, Inc. Announces First Quarter 2013 Earnings Release And Conference Call Information
11. Dynamic Healthcare Services Announces David Erb as Director of Sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... to their offering. The ... commercial environment for MedImmune to enter. The US ageing population ... to drive considerable growth for effective anti-influenza medications. The introduction ... considerably, but development is still in its infancy. ...
Breaking Medicine Technology:
(Date:6/27/2016)... California (PRWEB) , ... June 27, 2016 , ... "FCPX ... fully customizable inside of Final Cut Pro X," said Christina Austin - CEO of ... unique style. Final Cut Pro X users can now reveal the media ...
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
Breaking Medicine News(10 mins):